About this trial
Randomised trial comparing paclitaxel drug-coated balloon angioplasty with plain balloon angioplasty for femoropopliteal occlusive disease in patients with critical limb ischaemia.
Active
Paclitaxel vs Angioplasty in Critical Extremity Ischaemia
PAD-PACE
Intervention
Drug-Coated Balloon Angioplasty
Eligibility
This trial is investigating treatments for Peripheral Arterial Disease. Detailed age range and eligibility criteria will be published with the patient information pack.
Funding
Funding details for this trial are being finalised and will be published here shortly.
Latest News & Updates
Recent news related to this trial
PAD-PACE reports encouraging 12-month patency for drug-coated balloons
Mr Tunde Okafor · 28 Apr 2026
Interim 12-month data from the PAD-PACE study suggest paclitaxel drug-coated balloon angioplasty maintains vessel patency in patients with critical limb ischaemia, though the trial team urges caution pending full follow-up.
Read More →View patient-friendly version of this trial →